Cardiology

Can code 78802 be reported when performing imaging using bone agents for inflammatory disease?

An interventional cardiologist performs a PTCA in the LAD artery. The physician also performed angioplasty in the diagonal side branch of the patient’s LAD at the same session. How would we bill this in a hospital setting?

What are the circumstances that will meet the requirements for assigning 93458?

When both tibial/peroneal arteries in both legs are treated for lower extremity revascularization, what modifiers would we report?

Can you provide more clarity for 37215?

As a follow-up to last week’s question, if an embolic protection device cannot be used, which code do we report between the two?

When are codes 37215 and 37216 assigned?

For revascularization codes, what modifiers should be assigned if the tibial/peroneal arteries in both legs are treated?

What impact do the recent CMS updates to the Conditions of Participation (CoP) and Outpatient Prospective Payment System (OPPS) have on emergency preparedness and cardiac care, particularly in hospitals and Critical Access Hospitals?

What new payment policy is CMS implementing to support the use of domestically sourced Mo-99 in nuclear cardiology imaging?

Can you explain how CMS is addressing reimbursement for high-cost diagnostic radiopharmaceuticals used in nuclear cardiology?

What steps is CMS taking to improve access to high-cost specialty drugs, particularly for underserved populations served by Indian Health Service and tribal hospitals?